| # | Title | Journal | Year | Citations |
|---|
| 1 | Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification | Seminars in Liver Disease | 1999 | 3,350 |
| 2 | Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma | Seminars in Liver Disease | 2010 | 3,250 |
| 3 | Macrophages: Master Regulators of Inflammation and Fibrosis | Seminars in Liver Disease | 2010 | 1,112 |
| 4 | The Epidemiology of Cholangiocarcinoma | Seminars in Liver Disease | 2004 | 1,054 |
| 5 | Resection and Liver Transplantation for Hepatocellular Carcinoma | Seminars in Liver Disease | 2005 | 1,043 |
| 6 | Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects | Seminars in Liver Disease | 2010 | 945 |
| 7 | Epidemiology of Primary Liver Cancer | Seminars in Liver Disease | 1999 | 852 |
| 8 | Overview of MicroRNA Biology | Seminars in Liver Disease | 2015 | 835 |
| 9 | Epidemiology of Hepatitis C: Geographic Differences and Temporal Trends | Seminars in Liver Disease | 2000 | 816 |
| 10 | Genetic Heterogeneity of Hepatitis C Virus: Quasispecies and Genotypes | Seminars in Liver Disease | 1995 | 774 |
| 11 | Nonalcoholic Steatohepatitis: Definition and Pathology | Seminars in Liver Disease | 2001 | 759 |
| 12 | Pharmacological Treatment of Portal Hypertension: An Evidence-Based Approach | Seminars in Liver Disease | 1999 | 730 |
| 13 | Recovery, Persistence, and Sequelae in Hepatitis C Virus Infection: A Perspective on Long-Term Outcome | Seminars in Liver Disease | 2000 | 663 |
| 14 | History, Heterogeneity, Developmental Biology, and Functions of Quiescent Hepatic Stellate Cells | Seminars in Liver Disease | 2001 | 657 |
| 15 | The Epidemiology of Nonalcoholic Fatty Liver Disease: A Global Perspective | Seminars in Liver Disease | 2008 | 624 |
| 16 | Toxic Injury to Hepatic Sinusoids: Sinusoidal Obstruction Syndrome (Veno-Occlusive Disease) | Seminars in Liver Disease | 2002 | 596 |
| 17 | Fulminant and Subfulminant Liver Failure: Definitions and Causes | Seminars in Liver Disease | 1986 | 588 |
| 18 | Etiopathogenesis of Nonalcoholic Steatohepatitis | Seminars in Liver Disease | 2001 | 570 |
| 19 | Clinical Features and Natural History of Nonalcoholic Steatosis Syndromes | Seminars in Liver Disease | 2001 | 526 |
| 20 | Heterogeneity of Patients with Intermediate (BCLC B) Hepatocellular Carcinoma: Proposal for a Subclassification to Facilitate Treatment Decisions | Seminars in Liver Disease | 2013 | 508 |
| 21 | Genomics and Signaling Pathways in Hepatocellular Carcinoma | Seminars in Liver Disease | 2007 | 491 |
| 22 | Matrix as a Modulator of Hepatic Fibrogenesis | Seminars in Liver Disease | 2001 | 481 |
| 23 | Bacterial Infections, Sepsis, and Multiorgan Failure in Cirrhosis | Seminars in Liver Disease | 2008 | 460 |
| 24 | Epidemiology of Hepatitis C in the West | Seminars in Liver Disease | 1995 | 453 |
| 25 | Molecular Mechanisms of Lipotoxicity in Nonalcoholic Fatty Liver Disease | Seminars in Liver Disease | 2008 | 453 |
| 26 | Extracellular Matrix Degradation and the Role of Hepatic Stellate Cells | Seminars in Liver Disease | 2001 | 449 |
| 27 | Hepatic Stellate Cells as a Target for the Treatment of Liver Fibrosis | Seminars in Liver Disease | 2001 | 444 |
| 28 | Liver Transplantation for Hepatocellular Carcinoma | Seminars in Liver Disease | 1999 | 441 |
| 29 | Molecular Virology of Hepatitis B Virus | Seminars in Liver Disease | 2004 | 437 |
| 30 | Molecular Mechanisms of the Hepatotoxicity Caused by Acetaminophen | Seminars in Liver Disease | 1990 | 418 |
| 31 | Animal Models of Steatosis | Seminars in Liver Disease | 2001 | 398 |
| 32 | Cytokine Receptors and Signaling in Hepatic Stellate Cells | Seminars in Liver Disease | 2001 | 397 |
| 33 | Fatty Liver in Liver Transplantation and Surgery | Seminars in Liver Disease | 2001 | 396 |
| 34 | Nonalcoholic Steatohepatitis | Seminars in Liver Disease | 2004 | 394 |
| 35 | Mechanisms of Disease Progression in Nonalcoholic Fatty Liver Disease | Seminars in Liver Disease | 2008 | 382 |
| 36 | Cytokines in Alcoholic Liver Disease | Seminars in Liver Disease | 1999 | 380 |
| 37 | Hepatitis B: Evolving Epidemiology and Implications for Control | Seminars in Liver Disease | 1991 | 374 |
| 38 | Epidemiology and Natural History of Hepatitis B | Seminars in Liver Disease | 2005 | 373 |
| 39 | Hepatocellular Carcinoma: Epidemiology, Risk Factors, and Screening | Seminars in Liver Disease | 2005 | 368 |
| 40 | Hepatocyte Transplantation for the Treatment of Human Disease | Seminars in Liver Disease | 1999 | 363 |
| 41 | Natural History and Prognosis of Hepatitis B | Seminars in Liver Disease | 2003 | 359 |
| 42 | Structure of the Extracellular Matrix in Normal and Fibrotic Liver: Collagens and Glycoproteins | Seminars in Liver Disease | 1990 | 348 |
| 43 | Acute Liver Failure in the United States | Seminars in Liver Disease | 2003 | 347 |
| 44 | Hepatocellular Carcinoma: Epidemiology, Surveillance, and Diagnosis | Seminars in Liver Disease | 2010 | 339 |
| 45 | Epidemiology of Alcoholic Liver Disease | Seminars in Liver Disease | 1988 | 321 |
| 46 | Mitochondria in Steatohepatitis | Seminars in Liver Disease | 2001 | 321 |
| 47 | Nonalcoholic Fatty Liver Disease: Pathologic Patterns and Biopsy Evaluation in Clinical Research | Seminars in Liver Disease | 2012 | 321 |
| 48 | Cytokines and Fibrogenesis | Seminars in Liver Disease | 1999 | 319 |
| 49 | Coagulation Disorders in Liver Disease | Seminars in Liver Disease | 2002 | 316 |
| 50 | Progenitor Cells in Diseased Human Liver | Seminars in Liver Disease | 2003 | 313 |
